|
Anti-infective pharmaceuticals market in India is one of the most lucrative anti infectives markets of the world. In India, anti infectives is the largest contributor to domestic sales, contributing around 17.9%. Lack of proper drainage facilities and sanitation facilities are the causal factors of such vector borne diseases. The report begins with the introduction section which offers a brief classification of the anti infectives market. The market overview section provides an insight into the global market and then moves on to the Indian market, highlighting the market size and growth. A number of driving factors are acting as catalysts for the high growth of the industry. A detailed analysis of the drivers has been included in the next section. The fact that India has a huge disease burden of infectious diseases is considered to be the most important driving factor for the industry. Increasing number of vaccine approvals, increase in health insurance policies and introduction of newer and better drugs are the other major growth factors. The key challenges include pricing pressure in the overall market and logistic problems in the vaccine market. As the number of patients is continuously increasing in the country, the Government is taking various steps to spread awareness and control such infectious diseases. The Government initiatives section highlights the different disease control programmes started by the Government. These initiatives are mostly aimed at the proper distribution of drugs among all classes of patients. The Government has also taken initiatives to distribute drugs at subsidised rates at special stores, known as Jan Aushadhi stores. Various PPP projects have been undertaken and reforms have been made in the tax structure. Such initiatives promote the growth in the market. A brief overview of the drug regulations and patents is presented in the next section. It focuses the different stages of clinical trial that a drug must pass through. Drug regulations in India and drugs approved for marketing have been provided. The section also provides a list of important patent approvals for anti infective drugs. The competition section provides an overview of the competitive landscape in the industry. It includes a brief profile of the major players in the market along with their financials. It also includes the latest developments in the industry and it covers information such as patent approval, introduction of new drug molecules for infections treatment. The strategic recommendations section focuses on some effective strategic decisions which can be taken up by companies to increase their market shares. Foray into the production of adult vaccines and improvement in the logistics of the vaccine market will help the companies increase their customer base. Also, efficient marketing strategies, like strategic alliances of foreign companies with local manufacturers, or tie-ups of domestic manufacturers with Government bodies and non-governmental organizations will increase the profitability of the companies. Research On India (ROI) is Netscribes’ leading source for market intelligence on emerging sectors in India. Our topics provide a holistic view of an industry and are a spring board for entry strategies, private equity and venture capital investments, investor presentations and management discussions. For more details on the content of the report and our services you can contact us at sales@researchonindia.com Netscribes is a Market Intelligence Firm that supports Market Insights, Research & Analytics, Media & Publishing and Content Management. Netscribes services include Sales Insights, Market Intelligence, Social Media Insights, and Brand Surveillance for global clients. Netscribes (India) Pvt. Ltd. launches a report on the Anti-Infective Pharmaceuticals Market in India as part of Netscribes’ Healthcare Industry report series.
Related Articles -
Anti-Infective Pharmaceuticals Market in India, Anti-Infective Pharmaceuticals Market, Anti-Infective Pharmaceuticals Market in India 2011,
| 
